Showing 1731-1740 of 9174 results for "".
Fit in the Sun: What Experts Use and Recommend
https://practicaldermatology.com/topics/skin-cancer-photoprotection/fit-in-the-sun-what-experts-use-and-recommend/23533/Dermatologists share their favorite products to protect against UV and more.Emerging Technology: A Look at Nano-Pulse Stimulation
https://practicaldermatology.com/topics/skin-cancer-photoprotection/emerging-technology-a-look-at-nano-pulse-stimulation/23336/NPS is emerging as a novel technology platform for general and aesthetic dermatology.Up In Smoke? Exploring the use of CBD Oil in Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/up-in-smoke-exploring-the-use-of-cbd-oil-in-dermatology/23238/What, if anything, do we know about uber-popular CBD products?Biologics for Psoriasis: A Status Update
https://practicaldermatology.com/topics/psoriasis/biologics-for-psoriasis-a-status-update/23006/The field has grown substantially from the early 2000s to include now a dozen innovator systemic agents, a host of biosimilars, and soon JAK Inhibitors.BTL, Sciton Updates; Sun Gets PsO Real
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-btl-sciton-updates-sun-gets-pso-real/19601/BTL rolls out a small Emsculpt applicator to treat arms, thighs and calves at ASLMS. Sciton introduces JOULE X. In conjunction with Sun Pharma, the Association for Applied and Therapeutic Humor is offering strategies to help psoriasis patients navigate emotional challenges and uncomfortable psoriasiPhysician Spotlight: Vikash Oza, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-vikash-oza-md/20358/Access to newer medications remains a challenge in pediatric dermatology patients.Physician Spotlight: Steven R. Feldman, MD, PhD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-steven-r-feldman-md-phd/20541/The new thinking on improving adherence in dermatology.New Drugs in Psoriasis
https://practicaldermatology.com/topics/psoriasis/new-drugs-in-psoriasis/20933/The last two years have seen a number of new drugs approved to treat psoriasis—from targeted biologics to new topicals.Risks of Multiple Primary Melanomas
https://practicaldermatology.com/topics/practice-management/risks-of-multiple-primary-melanomas/21058/Studies offer clarity on risks and patterns after diagnosis, as well as survival outcomes.Currents: Use as Directed
https://practicaldermatology.com/topics/psoriasis/currents-use-as-directed/21082/Strategies to improve outcomes and enhance adherence in psoriasis, acne, eczema, and aesthetics